BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12199447)

  • 1. Follow up of oesophageal cancer therapy at the Kenyatta National Hospital, Nairobi.
    Ogendo SW
    East Afr Med J; 2001 Dec; 78(12):650-4. PubMed ID: 12199447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight change post oesophagectomy for carcinoma of oesophagus.
    Ogendo SW
    East Afr Med J; 2007 Jun; 84(6):271-8. PubMed ID: 18254469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factors affecting on long-time survival in patients with stage Ⅲ thoracic esophageal carcinoma after esophagectomy].
    Yang Q; Wang YX; He M; Li J; Qi Z; Zhu SC; Qiao XY
    Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):530-7. PubMed ID: 27531268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction.
    Zhang X; Watson DI; Jamieson GG; Lally C; Bessell JR; Devitt PG
    ANZ J Surg; 2005 Jul; 75(7):513-9. PubMed ID: 15972033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemoradiotherapy for esophageal cancer: is it worthwhile?
    Tamim WZ; Davidson RS; Quinlan RM; O'Shea MA; Orr RK; Swanson RS
    Arch Surg; 1998 Jul; 133(7):722-6. PubMed ID: 9687999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testicular cancer at Kenyatta National Hospital, Nairobi.
    Opot EN; Magoha GA
    East Afr Med J; 2000 Feb; 77(2):80-5. PubMed ID: 10774080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediastinoscopy-assisted oesophagectomy in T1 oesophageal cancer patients with serious comorbidities: a 5-year long-term follow-up.
    Wang J; Jiang NQ; Jiang B; Wang ZL; Zhang XY
    Interact Cardiovasc Thorac Surg; 2015 Apr; 20(4):477-81. PubMed ID: 25535180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain tumours at the Kenyatta National Hospital, Nairobi.
    Mwang'ombe NJ; Ombachi RB
    East Afr Med J; 2000 Aug; 77(8):444-7. PubMed ID: 12862071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary chemo-radiotherapy and selective oesophagectomy for oesophageal cancer: goal of cure with organ preservation.
    Wilson KS; Lim JT
    Radiother Oncol; 2000 Feb; 54(2):129-34. PubMed ID: 10699475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose definitive concomitant chemoradiotherapy in non-metastatic locally advanced esophageal cancer: toxicity and outcome.
    Hurmuzlu M; Monge OR; Smaaland R; Viste A
    Dis Esophagus; 2010 Apr; 23(3):244-52. PubMed ID: 19664075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of adjuvant therapies on patient survival and the recurrence patterns for resected stage IIa-IVa lower thoracic oesophageal squamous cell carcinoma.
    Wang Y; Zhu L; Xia W; Wu L; Wang F
    World J Surg Oncol; 2018 Nov; 16(1):216. PubMed ID: 30404621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 15-year review of esophagectomy for carcinoma of the esophagus and cardia.
    Millikan KW; Silverstein J; Hart V; Blair K; Bines S; Roberts J; Doolas A
    Arch Surg; 1995 Jun; 130(6):617-24. PubMed ID: 7763170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective comparison of clinical outcomes and quality of life measures between definitive chemoradiation alone and radical surgery for clinical stage II-III esophageal carcinoma.
    Yamashita H; Okuma K; Seto Y; Mori K; Kobayashi S; Wakui R; Ohtomo K; Nakagawa K
    J Surg Oncol; 2009 Nov; 100(6):435-41. PubMed ID: 19653240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction therapy for clinical T4 oesophageal carcinoma; a plea for continued surgical exploration.
    Van Raemdonck D; Van Cutsem E; Menten J; Ectors N; Coosemans W; De Leyn P; Lerut T
    Eur J Cardiothorac Surg; 1997 May; 11(5):828-37. PubMed ID: 9196296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of argyrophilic nucleolar organizer regions (AGNOR) in oesophageal cancer.
    Babu M; Mathur M; Gupta SD; Chattopadhyay TK
    Trop Gastroenterol; 1996; 17(1):57-60. PubMed ID: 8693588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer.
    Borghesi S; Hawkins MA; Tait D
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):221-6. PubMed ID: 18248970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postsurgical management of patients with breast cancer at Kenyatta National Hospital.
    Othieno-Abinya NA; Nyabola LO; Abwao HO; Ndege P
    East Afr Med J; 2002 Mar; 79(3):156-62. PubMed ID: 12389963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical therapy and chemoradiotherapy for postoperative recurrent esophageal cancer.
    Kubota K; Kuroda J; Yoshida M; Ohta K; Suwa T; Mafune K; Kawase T; Kitahara T; Kubo A; Kitajima M
    Hepatogastroenterology; 2013; 60(128):1961-5. PubMed ID: 24719935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of care and clinical outcomes in primary oesophageal gastrointestinal stromal tumours (GIST): A retrospective study of the French Sarcoma Group (FSG).
    Duffaud F; Meeus P; Bertucci F; Delhorme JB; Stoeckle E; Isambert N; Bompas E; Gagniere J; Bouché O; Toulmonde M; Salas S; Blay JY; Bonvalot S;
    Eur J Surg Oncol; 2017 Jun; 43(6):1110-1116. PubMed ID: 28433494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary mucoepidermoid carcinoma of the esophagus.
    Chen S; Chen Y; Yang J; Yang W; Weng H; Li H; Liu D
    J Thorac Oncol; 2011 Aug; 6(8):1426-31. PubMed ID: 21587086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.